DelveInsight’s “Polycystic Ovarian Syndrome (PCOS) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Polycystic Ovarian Syndrome market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Polycystic Ovarian Syndrome market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Polycystic Ovarian Syndrome (PCOS): An Overview
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. PCOS is characterized by excessive ovarian and/or adrenal androgen secretion. Intrinsic ovarian factors, such as altered steroidogenesis, and factors external to the ovary, such as hyperinsulinemia, contribute to excessive ovarian androgen production.
Characteristic features include more growing follicles in women with PCOS compared with normal controls with premature growth arrest of antral follicles at 5 to 8 mm. The classic ovarian phenotype of enlarged ovaries with string-of-pearl morphology and theca interstitial hyperplasia reflects androgen exposure; this morphology has also been observed in women with congenital adrenal hyperplasia (CAH) and female-to-male transgender individuals. Both genetic and lifestyle factors contribute to the development of the PCOS phenotype.
Polycystic Ovarian Syndrome (PCOS) Market Key Facts
-
According to Asuncion et al., the Polycystic Ovarian Syndrome prevalence rate in Spanish Caucasian women was found to be 6.5%.
-
As per the Centers for Disease Control and Prevention, Polycystic Ovarian Syndrome is one of the most common causes of female infertility, affecting 6% to 12% of US women of reproductive age.
- As per DelveInsight’s estimates, the total prevalent cases of Polycystic Ovary Syndrome (PCOS) in the US was the highest among the 7MM and is estimated to increase during the study period (2019-2032).
Polycystic Ovarian Syndrome (PCOS) Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Polycystic Ovarian Syndrome market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Polycystic Ovarian Syndrome market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Polycystic Ovarian Syndrome (PCOS) Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Polycystic Ovarian Syndrome (PCOS) Epidemiology Segmentation
-
Total Prevalent Cases of Polycystic Ovary Syndrome
-
Diagnosed Prevalent Cases of Polycystic Ovary Syndrome
-
Co-morbidities associated with Polycystic Ovary Syndrome
Polycystic Ovarian Syndrome (PCOS) Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Polycystic Ovarian Syndrome market or expected to get launched during the study period. The analysis covers the Polycystic Ovarian Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Polycystic Ovarian Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Polycystic Ovarian Syndrome Market Will Evolve by 2032 @
https://www.delveinsight.com/sample-request/polycystic-ovarian-syndrome-market
Polycystic Ovarian Syndrome Therapeutics Analysis
Companies across the globe are diligently working toward the development of novel treatment therapies, with a considerable amount of success over the years. The Polycystic Ovarian Syndrome therapeutics market has a promising outlook, with some of the best potential emerging therapies expected to hit the market in the near future.
Some of the key players in the Polycystic Ovarian Syndrome (PCOS) market include:
-
Zydus Discovery DMCC
-
Spruce Biosciences
-
Kindex Pharmaceuticals
-
AbbVie
And several others
Polycystic Ovarian Syndrome (PCOS) therapies covered in the report include:
-
Saroglitazar Magnesium
-
Tildacerfont
-
KDT 501
-
Elagolix
And many others.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @
https://www.delveinsight.com/sample-request/polycystic-ovarian-syndrome-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Polycystic Ovarian Syndrome Competitive Intelligence Analysis
4. Polycystic Ovarian Syndrome Market Overview at a Glance
5. Polycystic Ovarian Syndrome Disease Background and Overview
6. Polycystic Ovarian Syndrome Patient Journey
7. Polycystic Ovarian Syndrome Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Polycystic Ovarian Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Polycystic Ovarian Syndrome Unmet Needs
10. Key Endpoints of Polycystic Ovarian Syndrome Treatment
11. Polycystic Ovarian Syndrome Marketed Products
12. Polycystic Ovarian Syndrome Emerging Drugs and Latest Therapeutic Advances
13. Polycystic Ovarian Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Polycystic Ovarian Syndrome Market Outlook (In US, EU5, and Japan)
16. Polycystic Ovarian Syndrome Access and Reimbursement Overview
17. KOL Views on the Polycystic Ovarian Syndrome Market
18. Polycystic Ovarian Syndrome Market Drivers
19. Polycystic Ovarian Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/polycystic-ovarian-syndrome-market
Other Trending Healthcare Reports By DelveInsight
Polycystic Ovarian Syndrome Therapeutics Pipeline Analysis
“Polycystic Ovarian Syndrome Pipeline Insight, 2022” report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Polycystic Ovarian Syndrome market.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/